Related references
Note: Only part of the references are listed.Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies
Khalis Mustafayev et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
Soon Kyu Lee et al.
CLINICAL INFECTIOUS DISEASES (2021)
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
George Lau et al.
HEPATOLOGY INTERNATIONAL (2021)
Hepatitis B virus persistence and reactivation
Yu Shi et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies
Danielle J. Smalls et al.
PHARMACOTHERAPY (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network
Ye Eun Kwak et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Preventing Hepatitis B Reactivation During Anti-CD20 Antibody Treatment in the Veterans Health Administration
A. Jasmine Bullard et al.
HEPATOLOGY COMMUNICATIONS (2018)
Improvements in Hepatitis B Virus Screening Before Rituximab Therapy: A Community-Based, Safety-Net Hospital Experience
Kevin Junus et al.
CANCER (2017)
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba et al.
GASTROENTEROLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
Yuri Cho et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Prevention of Hepatitis B reactivation in the setting of immunosuppression
Venessa Pattullo
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Robert P. Perrillo et al.
GASTROENTEROLOGY (2015)
Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases
J. P. Hwang et al.
JOURNAL OF VIRAL HEPATITIS (2015)
The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System
Wei-Chih Sun et al.
PLOS ONE (2015)
AGA Institute Guidelines on Hepatitis B Reactivation (HBVr): Clinical Decision Support Tool
GASTROENTEROLOGY (2014)
Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids
Tae-Wan Kim et al.
RESPIROLOGY (2010)
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Laura Belloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
Gilles Salles et al.
BLOOD (2008)
Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones
T Pollicino et al.
GASTROENTEROLOGY (2006)
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma
R Marcus et al.
BLOOD (2005)
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
BRITISH JOURNAL OF CANCER (2004)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Structural organization of the hepatitis B virus minichromosome
CT Bock et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Share Paper
